Evaluation of the drug-drug interaction potential of the novel hepatitis B and D virus entry inhibitor bulevirtide at OATP1B in healthy volunteers

dc.contributor.author	Haag, Mathias
dc.contributor.author	Hofmann, Ute
dc.contributor.author	Schwab, Matthias
dc.date.accessioned	2023-07-13T10:42:49Z
dc.date.available	2023-07-13T10:42:49Z
dc.date.issued	2023
dc.identifier.issn	1663-9812
dc.identifier.uri	http://hdl.handle.net/10900/143373
dc.language.iso	en	de_DE
dc.publisher	Frontiers Media Sa	de_DE
dc.relation.uri	http://dx.doi.org/10.3389/fphar.2023.1128547	de_DE
dc.subject.ddc	610	de_DE
dc.title	Evaluation of the drug-drug interaction potential of the novel hepatitis B and D virus entry inhibitor bulevirtide at OATP1B in healthy volunteers	de_DE
dc.type	Article	de_DE
utue.quellen.id	20230619000000_00467
utue.personen.roh	Zhu, Vanessa
utue.personen.roh	Burhenne, Juergen
utue.personen.roh	Weiss, Johanna
utue.personen.roh	Haag, Mathias
utue.personen.roh	Hofmann, Ute
utue.personen.roh	Schwab, Matthias
utue.personen.roh	Urban, Stephan
utue.personen.roh	Mikus, Gerd
utue.personen.roh	Czock, David
utue.personen.roh	Haefeli, Walter E.
utue.personen.roh	Blank, Antje
dcterms.isPartOf.ZSTitelID	Frontiers in Pharmacology	de_DE
dcterms.isPartOf.ZS-Issue	Article 1128547	de_DE
dcterms.isPartOf.ZS-Volume	14	de_DE
utue.fakultaet	07 Mathematisch-Naturwissenschaftliche Fakultät	de_DE